NYK1 Secrets Limited – Trademark Portfolio
Entity Type: 99
NYK1 Secrets Limited holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 8 trademarks are registered and 1 is pending. Notable registered marks include NYK1, MEGAFILE, NAILBOND, TANFORCE, and BROWFORCE. The owner is based in Heckmondwike.
Unit 7G
Ponderosa Business Park, Smithies Lane
Heckmondwike WF160PR
Showing of trademarks Trademarks
Trademark Classifications
NYK1 Secrets Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does NYK1 Secrets Limited have?
NYK1 Secrets Limited has 10 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 pending, 1 abandoned.
What trademark classes does NYK1 Secrets Limited file in?
NYK1 Secrets Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 8 (Hand Tools), Class 21 (Housewares). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are NYK1 Secrets Limited's most well-known trademarks?
NYK1 Secrets Limited's registered trademark portfolio includes well-known marks such as NYK1, MEGAFILE, NAILBOND, TANFORCE, and BROWFORCE. These are among 8 currently registered trademarks in the portfolio.
What is NYK1 Secrets Limited's trademark registration success rate?
NYK1 Secrets Limited has a 89% trademark registration rate, with 8 out of 9 resolved applications resulting in successful registration. Currently, 1 application is pending review.